Friday - January 10, 2025
Ropes & Gray Represents G1 Therapeutics in Pepper Bio Global License Agreement
May 01, 2024
BOSTON, Massachusetts, May 1 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray advised G1 Therapeutics in a global licensing agreement, excluding the Asia Pacific region, with Pepper Bio for lerociclib for all indications except for certain radioprotectant uses.

Pepper Bio's in-licensed therapeutic lerociclib has demonstrated efficacy in clinical studies across various cancer types, including certain metastatic breast cancer. The transactio . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products